Evidence map›Paper›PMID 37180207›Full record

ArticleMediterranean journal of hematology and infectious diseases2023

Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature.

Riccardo Paggi, Francesca Mariotti, Jessica Mencarini, Silvia Bresci, Irene Campolmi, Filippo Bartalesi, Beatrice Borchi, Luca Nassi, Benedetta Sordi, Alessandro Maria Vannucchi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Riccardo PaggiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Francesca MariottiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Jessica MencariniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Silvia BresciInfectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Irene CampolmiInfectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Filippo BartalesiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Beatrice BorchiInfectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
Luca NassiHematology Unit, Careggi University Hospital, Florence, Italy.
Benedetta SordiHematology Unit, Careggi University Hospital, Florence, Italy.
Alessandro Maria VannucchiCenter for Innovation and Research in Myeloproliferative Neoplasms, Hematology Unit, Careggi University Hospital, University of Florence, Florence, Italy.
Alessandro BartoloniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of specific inhibitory drugs of intracellular signalling pathways (such as Bruton-Kinase inhibitors) for the treatment of Waldenström's macroglobulinaemia (WM) is a recognised risk factor for

Indexed as

Bruton Kinase InhibitorsInvasive AspergillosisLacrimal Glands LymphomaOrbital LymphomaWaldenström’s Macroglobulinemia

Identifiers

PMID37180207
PMCPMC10171213
OpenAlexW4367393901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.